THE INTERACTION OF L-TRIIODOTHYRONINE AND 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN ON AH-RECEPTOR-MEDIATED HEPATIC PHASE-I AND PHASE-II ENZYMES AND IODOTHYRONINE 5'-DEIODINASE IN THYROIDECTOMIZED RATS

被引:16
作者
ELTOM, SE
BABISH, JG
FERGUSON, DC
机构
[1] CORNELL UNIV, NEW YORK STATE COLL VET MED, DEPT PHARMACOL, ITHACA, NY 14853 USA
[2] UNIV GEORGIA, COLL VET MED, DEPT PHYSIOL & PHARMACOL, ATHENS, GA 30602 USA
关键词
DIOXIN; THYROID HORMONES; ARYLHYDROCARBON RECEPTOR; DRUG METABOLISM;
D O I
10.1016/0378-4274(92)90139-B
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Across all levels of L-triiodothyronine (L-T3) treatment, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) resulted in increased hepatic cytochrome P-450-associated activities of 7-ethoxycoumarin O-deethylase (ECOD), 7-ethoxyresorufin O-dealkylase (EROD) and aryl hydrocarbon hydroxylase (AHH). The treatment of thyroidectomized rats with L-T3 at physiologic replacement levels in concert with TCDD produced an increase in ECOD, EROD and AHH activity above that seen with only TCDD. TCDD as well as L-T3 enhanced the activity of hepatic 1-naphthol glucuronyl transferase (NGT). In addition, the combined effect of L-T3 and TCDD resulted in similar levels of induction of NGT at both physiologic and supraphysiologic doses Of L-T3. TCDD treatment resulted in elevated serum T3 levels at both physiologic and supraphysiologic levels of t.-T3. One TCDD dose inhibited hepatic microsomal 3,3',5'-triiodothyronine (reverse T3) 5'-deiodinase activity by 61 % in thyroidectomized. T3-untreated rats. The inhibition of 5'-deiodinase activity was partially overcome by increasing the T3 dose.
引用
收藏
页码:125 / 139
页数:15
相关论文
共 57 条
[31]   2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN (TCDD) AS A POTENT AND PERSISTENT THYROXINE AGONIST - A MECHANISTIC MODEL FOR TOXICITY BASED ON MOLECULAR REACTIVITY [J].
MCKINNEY, JD ;
FAWKES, J ;
JORDAN, S ;
CHAE, K ;
OATLEY, S ;
COLEMAN, RE ;
BRINER, W .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1985, 61 (SEP) :41-53
[32]  
MULLER D, 1983, BIOMED BIOCHIM ACTA, V42, P981
[33]  
MULLER D, 1985, BIOMED BIOCHIM ACTA, V44, P1171
[34]  
Neal R A, 1979, Ann N Y Acad Sci, V320, P204, DOI 10.1111/j.1749-6632.1979.tb13145.x
[35]   THE AH LOCUS, A MULTIGENE FAMILY NECESSARY FOR SURVIVAL IN A CHEMICALLY ADVERSE ENVIRONMENT - COMPARISON WITH THE IMMUNE-SYSTEM [J].
NEBERT, DW ;
NEGISHI, M ;
LANG, MA ;
HJELMELAND, LM ;
EISEN, HJ .
ADVANCES IN GENETICS, 1982, 21 :1-52
[36]   GENETIC MECHANISMS CONTROLLING THE INDUCTION OF POLYSUBSTRATE MONO-OXYGENASE (P-450) ACTIVITIES [J].
NEBERT, DW ;
EISEN, HJ ;
NEGISHI, M ;
LANG, MA ;
HJELMELAND, LM ;
OKEY, AB .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1981, 21 :431-462
[37]   GENETIC EXPRESSION OF ARYL-HYDROCARBON HYDROXYLASE-ACTIVITY IN MOUSE [J].
NEBERT, DW ;
ROBINSON, JR ;
NIWA, A ;
KUMAKI, K ;
POLAND, AP .
JOURNAL OF CELLULAR PHYSIOLOGY, 1975, 85 (02) :393-414
[38]   P450 GENES - STRUCTURE, EVOLUTION, AND REGULATION [J].
NEBERT, DW ;
GONZALEZ, FJ .
ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 :945-993
[39]   REGULATION OF THE MAMMALIAN CYTOCHROME-P1-450 (CYP1A1) GENE [J].
NEBERT, DW ;
JONES, JE .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY, 1989, 21 (03) :243-252
[40]   TWO-DIMENSIONAL GEL ANALYSIS OF RAT-LIVER NUCLEAR PROTEINS AFTER THYROIDECTOMY AND THYROID-HORMONE TREATMENT [J].
NIKODEM, VM ;
TRUS, BL ;
RALL, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (07) :4411-4415